CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06626659
NCT06626659N/ACompleted

Lipoprotein (a) and Vascular Regenerative Cell Content

Canadian Medical and Surgical Knowledge Translation Research Group·observational·Posted Oct 4, 2024·Updated Dec 29, 2025

In Brief

An observational study for Cardiovascular Diseases and 3 related conditions. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

Lp(a)-VRCE is an observational, cross sectional study looking at vessel reparative stem cell content in people with and without elevated lipoprotein (a) \[Lp(a)\]. Specifically, the type and number of these cells in peripheral blood samples will be measured in participants with Lp(a) ≥100 nmol/L and compared to participants with Lp(a) \< 100 nmol/L. Determining the presence or absence of specific cells with blood vessel repair capacity in participants with high Lp(a) will further our knowledge of potential mechanisms through which Lp(a) influences cardiovascular health.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedOct 4, 2024
Enrollment StartOct 5, 2024
Primary CompletionDec 3, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.7 years ago